Zizhou Zhang
Guangzhou International Bio Island
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Deficient FANCL Predisposes to Endothelial Damage: A New Therapeutic Target for Pulmonary Hypertension.
Journal: American journal of respiratory and critical care medicine
Published: June 06, 2025
Deficiency of Endothelial Piezo2 Impairs Pulmonary Vascular Angiogenesis and Predisposes Pulmonary Hypertension.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: January 06, 2025
The HIF2α-dependent upregulation of SETDB1 facilitates hypoxia-induced functional and phenotypical changes of pulmonary microvascular endothelial cells.
Journal: American journal of physiology. Cell physiology
Published: November 04, 2024
Oral administration of pioglitazone inhibits pulmonary hypertension by regulating the gut microbiome and plasma metabolome in male rats.
Journal: Physiological reports
Published: October 07, 2024
Distinct airway mycobiome signature in patients with pulmonary hypertension and subgroups.
Journal: BMC medicine
Published: August 18, 2024
Aloperine protects pulmonary hypertension via triggering PPARγ signaling and inhibiting calcium regulatory pathway in pulmonary arterial smooth muscle cells.
Journal: American journal of physiology. Cell physiology
Published: September 04, 2023
Microbiome and metabolome dysbiosis of the gut-lung axis in pulmonary hypertension.
Journal: Microbiological research
Published: February 01, 2022
Airway delivery of Streptococcus salivarius is sufficient to induce experimental pulmonary hypertension in rats.
Journal: British journal of pharmacology
Published: October 14, 2021
Upregulation of Piezo1 (Piezo Type Mechanosensitive Ion Channel Component 1) Enhances the Intracellular Free Calcium in Pulmonary Arterial Smooth Muscle Cells From Idiopathic Pulmonary Arterial Hypertension Patients.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: April 05, 2021
The causality between CFTR and pulmonary hypertension: insights from Mendelian randomization studies.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: January 24, 2021
Dysregulation of BMP9/BMPR2/SMAD signalling pathway contributes to pulmonary fibrosis and pulmonary hypertension induced by bleomycin in rats.
Journal: British journal of pharmacology
Published: February 21, 2020
Last Updated: 09/26/2026